Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Reata Pharma Announces $350 Million Strategic Investment from Blackstone Life Sciences

Shares of Reata Pharmaceuticals traded 30% higher after reporting that Blackstone Life Sciences will invest $350 million in the company to advance bardoxolone methyl as a potential therapy for Alport syndrome and other rare and serious chronic kidney diseases. Clin...

Price of Gold Fundamental Daily Forecast – ...

Price of Gold Fundamental Daily Forecast – Continues to Drift as Traders Await Next Catalyst to Move Prices If investors were concerned about President Trump being removed from office then Treasurys and the Japanese Yen would be skyrocketing, and gold would be right beh...

The Daily Sentiment Suggests a Major Market Top Is Near

As of November 18 th , sentiment for the S&P futures and the Nasdaq Index is approaching nosebleed territory. The infusion of hundreds of billions of dollars on the Fed's balance sheet since Mid-September has pumped the stock market higher in response. But no matter how...

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...

Yesterday Was Supposed To Be a Reversal, Right?

Stocks have closed between two strong resistances yesterday – between the upper border of March’s gap and the 61.8% Fibonacci retracement. But the overnight rise in US-China tensions (this time, regarding Hong Kong), sent the S&P 500 futures below the key Fibon...

Was Yesterday's S&P 500 Plunge a Game Changer?

Post-Fed selling took on a life of its own yesterday – so far so good, but isn't the downswing getting a little ahead of itself? Today, it's primarily the credit and debt markets that will shed more light. And what about today's inflation expectations and consumer sentiment da...

April 21st 2020, Crypto Chartbook: Uncertainty – opportunity in disguise

Uncertainty – opportunity in disguise We have just entered into a future with a higher degree of uncertainty. Times of more rapid change promise innovation, a higher degree of risk taking, in short evolution on steroids awaits. History shows that times like these spell op...

New Day, New Test of the Great S&P 500 Bull Run

Egged on by the horrendous retail sales data, S&P 500 intraday decline has gathered steam yesterday. An 8.7% drop in consumer spending can’t be just waved off. Neither can the Empire State Manufacturing Index at -78.2. We have the impression that the world is w...

Has the Stock Downswing Started in Earnest?

It turned out that the late Tuesday Kaplan and Kashkari pronouncements were an opening act in yesterday’s Powell appearance. Fed Chair’s realistic and grim assessment just served to put pressure to throw yet another lifeline to the real economy....

Fed Goes All In - As In All In, and Stocks Like It

On the heels of the Fed’s unlimited QE promise, the S&P 500 sprang to life finally. All the gains though were given up in less than three hours. As the futures keep climbing overnight, does it herald a turnaround? Let’s start our analysis wi...
1 2 3 4 5 6 7 8 9 10 ...